Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50p -3.09% 47.00p 46.00p 48.00p 48.50p 47.00p 48.50p 119,781 11:47:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.5 -7.4 -8.7 - 55.03

Angle Share Discussion Threads

Showing 48301 to 48325 of 48325 messages
Chat Pages: 1933  1932  1931  1930  1929  1928  1927  1926  1925  1924  1923  1922  Older
DateSubjectAuthorDiscuss
21/4/2018
10:07
Bones, How many AGM's have you attended? I don't need to argue the case for AGL, the KOL's are doing a great job in doing that and why should I give you the benefit from my hard work and research? I don't think Dermot Keane would have invested millions of his own money in AGL if he shared your negativity, do you?
jelenko
21/4/2018
08:19
Well said escape.
stevelauren23
20/4/2018
23:34
Not the right time for the final judgement on angle. Wait for fda approval, and approved methodology for specific cancer. Then gauge sales performance. I would say still a couple of years to go before angle can be condemned or celebrated.
escapetohome
20/4/2018
21:19
Lmao jelenko I suggest you read back over many years . You will find I'm the only one who knows what they are talking about on here . No FDA approval correct Fund raising correct No sales correct All against the so called people in the know . Make up your own minds who knows what they are talking about here but so far you have posted nothing to argue my comments or provided anything worthwhile
bones698
20/4/2018
20:21
You don't know what you are talking about.
jelenko
20/4/2018
20:09
Guys the whole reason this won't do any higher is the total failure in selling units . They geared up to increase sales nearly 2 years ago with new facilities etc but no meaning sales have ever arrived . The FDA approval still hadn't come which is worrying given that was also due over 18 months ago if you believe those who supposedly know what they are talking about on this BB. Until they can start to deliver meaningful sales and stop haemoraging cash this won't go higher intact it's likely to drop as funding aporoaches . That may be 12 months away but that will come around fast and there are no signs this company is anywhere near break even or will be for many years . The tech is good that is something I have never argued here but as for running the company and their approach and lack of results in afraid that I do see as almost total failure . Will it ever happen remains to be seen but many in here thought they would be rich by now and that simply hasn't happened in fact the goal posts keep getting further away with each fund raising .
bones698
20/4/2018
19:43
Agree willfy. Have had time and again, ground breaking news, with no meaningful effect on the market cap. Could there be some skullduggery going on?
4legs
20/4/2018
16:04
4legs, anyone who loses patience in Angle needs their head examined....Submitting data for breast cancer FDA this year, hopefully granted early 2019, lots more going on in the background!
willfy
20/4/2018
14:15
Should think a lot of shareholders are loosing patience. Not high volume, though a constant drip of sales, creating more sales. I would have thought buys in the coming days will appear. Possibly even a bid in the not too distant future.
4legs
20/4/2018
13:48
Seems some party is keen to keep the market cap down by feeding the sell side. Might just be pressure of sells, but I'm not so sure. Not aware of any/much shorting.
waterloo01
20/4/2018
11:43
So it seems. Thought it would have dried up by now. £55m market cap just seems way too low given the potential. I'll keep drip buying, especially under 50p
waterloo01
20/4/2018
11:37
Buying active below the mid-price.Still looks like there is a bit of a stock overhang dragging this down.
longshanks
20/4/2018
10:36
Hoping for a decent write up in a Sunday paper? It seems that the word is around with the movers and shakers in academic, research and some big pharma, but the ‘stock market’ doesn’t really wish to engage.
semper vigilans
20/4/2018
10:28
Cant fault AN's work rate on PR...
bagpuss67
20/4/2018
09:55
Totally Irrelevant Post... But Hey its Friday - Some Light Reading in the Sun: (This may or may not have been posted?!) Feb 18 - Snippet from Simon Cawkwells Blog 'aka' Evil Knievil (Short Seller): "I spent the bulk of Friday last attending Bob Catto and Jeremy Lyon’s old boys’ luncheon club, located on this occasion at the Naval Club hired by Hobart, their employer. I describe the boys as old boys given that the minimum age of those attending seemed to me to be at least 70. This was underlined by the first presentation which was by Angle Plc (LON:AGL) with their Andrew Newland on its product, Parsortix. I have two observations: (i) Andrew is clearly honest and believes that Parsortix is the way forward for economic diagnosis of cancer; (ii) I know nothing of potential competitors – it therefore follows that I cannot comment on Parsortix. But if Andrew is not completely screwy you would not want to be short of Angle."
5oletrader
20/4/2018
09:49
These reds appear to be buys this morning. I just tried a dummy buy and was quoted 47.45.
maxie23
20/4/2018
08:54
I am surprised there has been no follow through with the share price after yesterdays very encouraging news.
alloa2003
19/4/2018
17:31
I agree Space - it does make us sound like wise old people! Tomorrow’s World with Raymond Baxter used to be exciting to us, as did the gadgets in Bond films: technological advances are just taken for granted now. Audio with AN on Proactive Investors worth a listen.
semper vigilans
19/4/2018
16:36
To be honest Nige, it should have happened a few years back. Parsortix is a hell of a lot more use than most of the social media offerings that have reached the stars mkt-wise, despite gobbling millions/billions per year. It just goes to show what a perverse world we live in when drivel is valued more highly than genuine worth to society.
spaceparallax
19/4/2018
15:59
Too many people selling who picked up shares at 35p in the placing. Hope they regret it after successful trials and FDS are achieved.
mikepompeyfan
19/4/2018
15:53
Banshee, To add you your post, like Cellsearch, Biocept is another system that uses antibody enrichment - ie. it uses antibodies to target specific markers on the tumour cell surface. This means it only picks up cells expressing those markers and only if they're expressed in sufficient numbers. It's also a lab based system - doctors have to send the blood sample to their labs for processing. Think FDA approval will be a game changer (although there may be a time lag) , especially if the FISH HER2 status testing is successful. Going to be an interesting few months.
bermudashorts
19/4/2018
14:42
You got to love that all this work is going on without Angle being directly involved. Just companies reporting on what they are achieving. Potentially trans formative in personalised medicine. Someone must be thinking of running a larger trial after this paper and going for straight FDA approval for use in testing drugs ex vivo
waterloo01
19/4/2018
14:41
There are CTC stocks listed on the NASDAQ, Biocept, for example, with testing revenues of circa $4 million a year and growing at circa 10%+ q on q. They do a clinical CTC lab test for MBC and 5 other cancers including Prostate, current cap $17 million US, but has been over $100mill in the past. No FDA of course, but still in actual clinical use. I don't think FDA approval will make the level of difference that some here do, but it will certainly be of benefit to the share price
banshee
19/4/2018
14:33
hTtps://www.youtube.com/watch?v=yfBfdJF6cyM AN interview
waterloo01
19/4/2018
14:31
Space, could you let me know what day that will be so I can put it in my diary? Will it be before the blue moon or after the 12th of never?
nigelc43
Chat Pages: 1933  1932  1931  1930  1929  1928  1927  1926  1925  1924  1923  1922  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180421 11:53:57